v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Non-Controlling Interests
Total
Balance at Dec. 31, 2024 $ 3 $ 28 $ 763,573 $ (740,867) $ (24,381) $ (1,644)
Balance (in shares) at Dec. 31, 2024 3,427,138 27,908,839        
Stock-based compensation expense     23,082     23,082
Issuance of common stock related to equity plans   $ 1 (1)      
Issuance of common stock related to equity plans (in shares)   1,171,647        
Issuance of common stock under ESPP     43     43
Issuance of common stock under ESPP (in shares)   35,546        
Issuance of stock for equity offerings, net   $ 1 1,008     1,009
Issuance of stock for equity offerings, net (in shares)   539,563        
Redemption of partner company preferred shares     (265)     (265)
Partner companies' offerings, net and warrant exercises     54,094     54,094
Partner companies' at-the-market offering, net     6,740     6,740
Issuance of common stock under partner company's ESPP     99     99
Partner company's dividends declared and paid     (332)     (332)
Exercise of warrants     593     593
Exercise of warrants (in shares)   97,200        
Partner company's exercise of options for cash     240     240
Deconsolidation of subsidiary non-controlling interests         (9,931) (9,931)
Non-controlling interest in partner companies     (69,018)   69,018  
Attributable to non-controlling interest         (41,247) (41,247)
Net income attributable to common stockholders       4,902   4,902
Balance at Jun. 30, 2025 $ 3 $ 30 779,856 (735,965) (6,541) 37,383
Balance (in shares) at Jun. 30, 2025 3,427,138 29,752,795        
Balance at Mar. 31, 2025 $ 3 $ 30 773,668 (751,451) 10,236 32,486
Balance (in shares) at Mar. 31, 2025 3,427,138 29,554,966        
Stock-based compensation expense     16,793     16,793
Issuance of common stock related to equity plans (in shares)   75,083        
Issuance of common stock under ESPP     43     43
Issuance of common stock under ESPP (in shares)   35,546        
Redemption of partner company preferred shares     (115)     (115)
Partner companies' offerings, net and warrant exercises     9,186     9,186
Partner company's dividends declared and paid     (166)     (166)
Exercise of warrants     576     576
Exercise of warrants (in shares)   87,200        
Partner company's exercise of options for cash     165     165
Deconsolidation of subsidiary non-controlling interests         (9,931) (9,931)
Non-controlling interest in partner companies     (20,294)   20,294  
Attributable to non-controlling interest         (27,140) (27,140)
Net income attributable to common stockholders       15,486   15,486
Balance at Jun. 30, 2025 $ 3 $ 30 779,856 (735,965) (6,541) 37,383
Balance (in shares) at Jun. 30, 2025 3,427,138 29,752,795        
Balance at Dec. 31, 2025 $ 3 $ 31 783,891 (734,052) 12,310 62,183
Balance (in shares) at Dec. 31, 2025 3,427,138 31,364,094        
Stock-based compensation expense     4,634     4,634
Issuance of common stock related to equity plans   $ 1 (1)      
Issuance of common stock related to equity plans (in shares)   1,218,535        
Issuance of common stock under ESPP     74     74
Issuance of common stock under ESPP (in shares)   34,087        
Exchange of partner company preferred shares     (165)     (165)
Issuance of common stock under partner company's ESPP     148     148
Exercise of warrants   $ 1 1,217     1,218
Exercise of warrants (in shares)   694,296        
Partner company's exercise of options for cash     230     230
Non-controlling interest in partner companies     (1,777)   1,777  
Attributable to non-controlling interest         27,859 27,859
Net income attributable to common stockholders       109,905   109,905
Balance at Jun. 30, 2026 $ 3 $ 33 788,251 (624,147) 41,946 206,086
Balance (in shares) at Jun. 30, 2026 3,427,138 33,311,012        
Balance at Mar. 31, 2026 $ 3 $ 33 785,851 (623,679) 40,166 202,374
Balance (in shares) at Mar. 31, 2026 3,427,138 33,186,671        
Stock-based compensation expense     2,878     2,878
Issuance of common stock related to equity plans (in shares)   90,254        
Issuance of common stock under ESPP     74     74
Issuance of common stock under ESPP (in shares)   34,087        
Partner company's exercise of options for cash     158     158
Non-controlling interest in partner companies     (710)   710  
Attributable to non-controlling interest         1,070 1,070
Net income attributable to common stockholders       (468)   (468)
Balance at Jun. 30, 2026 $ 3 $ 33 $ 788,251 $ (624,147) $ 41,946 $ 206,086
Balance (in shares) at Jun. 30, 2026 3,427,138 33,311,012